Prism AI Therapeutics Email Formats

About Prism AI Therapeutics

Prism AI Therapeutics provides an AI-first multi-omics management platform that uniquely enables biotech companies and health systems to unlock the value of real-world multi-omic data and develop the next generation of drugs and biomarkers. The platform is powered by proprietary quantum mechanics-based AI/ML, and is supported by end-to-end global biospecimen sourcing and molecular profiling services. We and our partners have experimentally validated that our AI/ML is uniquely able to make accurate, precise, clinically actionable, and mechanistically interpretable discoveries from real-world multi-omic data. We excel in (i) discovering biomarkers of response and survival, disease models, and drug targets that consistently validate across studies and over time in federated, small-cohort, noisy, and high-dimensional data, (ii) integrating multi-omic data for discovery and validation of multi-modal predictors, (iii) separating the predictors from normal demographic variations, and (iv) removing systematic batch effects from the data. Let’s join forces to conquer disease.

View contact profiles from Prism AI Therapeutics